Marker combinations provide more informative profiles than any single marker alone. Surface markers help separate cell populations, while intracellular markers can reveal functional states such as cytokine production or proliferation. Considering several signals together helps researchers distinguish closely related subsets and connect a cell’s phenotype with its origin or activity in a blood or tissue sample.
Flow cytometry measures fluorescent signals from individual labeled cells as they pass through the instrument. Fluorescent antibodies bind selected surface or intracellular markers, allowing researchers to assess marker expression across cell populations. This single-cell approach supports the identification of subsets and the measurement of activation, proliferation, or cytokine production within those populations.
Each approach contributes different evidence about an immune cell. Morphology provides visible cellular features, marker analysis identifies phenotype and population relationships, and functional assays reveal activities such as proliferation or cytokine production. Combining these measurements gives a broader interpretation than any one method and helps link how cells appear with what they do.
Cell identity is informed by characteristics associated with phenotype and origin, whereas cell state reflects changes such as activation, proliferation, or cytokine production. Surface and intracellular markers can capture both dimensions, but functional assays add direct evidence of activity. Separating these questions helps researchers interpret whether a population differs in composition, behavior, or both.
A typical workflow selects the cell source, examines relevant cellular features, labels cells with fluorescent antibodies when using flow cytometry, and measures marker expression individually. Researchers then integrate surface or intracellular marker data with functional assay results. Comparing these measurements across samples can reveal changes in immune populations, activation, proliferation, or cytokine production.
The approach is useful when researchers need to examine immune changes associated with infection, inflammation, cancer, autoimmunity, or vaccination. It can also support the development and evaluation of immunotherapies by showing how immune populations or their functional states change. Tracking cells in blood or tissues provides a way to compare immune responses across conditions or over time.